Recalls / Generics / Bupivacaine Hydrochloride And Epinephrine Bitartrate
Bupivacaine Hydrochloride And Epinephrine Bitartrate
5 FDA drug recalls involving generic “Bupivacaine Hydrochloride And Epinephrine Bitartrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-11-22 | Class II | Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.25% | Fresenius Kabi USA, LLC |
| 2022-11-22 | Class II | Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0 | Fresenius Kabi USA, LLC |
| 2022-11-22 | Class II | Sensorcaine (Bupivacaine HCl and Epinephrine Injection, USP) with Epinephrine 1:200,000 (as bitartrate), 0.5%, | Fresenius Kabi USA, LLC |
| 2020-12-10 | Class II | Sensorcaine-MPF (Bupivacaine HCl and Epinephrine Injection, USP), 0.5%, 150 mg per 30 mL (5 mg per mL), 30 mL | Fresenius Kabi USA, LLC |
| 2016-04-25 | Class II | Sensorcaine- MPF (Bupivacaine HCI Injection, USP), 0.75% in a 30 mL Single Dose Vial, Rx only, Fresenius Kabi | Fresenius Kabi USA, LLC |